In addition to being induced at high frequencies by ovarian cancer ascites, TNFR2+ Tregs were also potent suppressors when compared to the TNFR2− T cell fraction, which was in agreement with previous studies (13, 18). This evidence concerns the gene TNFRSF1B and ovarian carcinoma.